Global Heart Pump Device Market Size Study & Forecast, by Product (Ventricular Assist Devices, Intra-aortic Balloon Pumps, TAH), by Type, by Therapy and Regional Forecasts 2025-2035

Description

The Global Heart Pump Device Market is valued at approximately USD 3.78 billion in 2024 and is anticipated to expand at an impressive CAGR of 21.60% throughout the forecast period of 2025-2035. Heart pump devices, ranging from ventricular assist devices to total artificial hearts, are critical life-sustaining technologies designed to support or completely replace the pumping function of a failing heart. With heart failure cases rising at an alarming rate globally, fueled by the aging population, lifestyle-related cardiovascular diseases, and post-myocardial complications, these devices are becoming indispensable in advanced cardiac care. The growing emphasis on improving survival rates, reducing hospital readmissions, and enhancing patients' quality of life has further propelled adoption across hospitals and transplant centers.

The escalating prevalence of advanced heart failure has triggered surging demand for mechanical circulatory support systems. According to the World Health Organization, cardiovascular diseases continue to remain the leading cause of global mortality, accounting for nearly 18 million deaths annually. This clinical burden has intensified the urgency to deploy sophisticated heart pump technologies as both bridge-to-transplant solutions and long-term therapies for patients ineligible for transplantation. Moreover, ongoing advancements in miniaturization, durability of implantable pumps, and hybrid therapeutic approaches are creating significant opportunities for manufacturers. However, high device costs, risks of infection and thrombosis, and limited access in low-income regions act as deterrents, challenging widespread adoption.

From a regional perspective, North America currently dominates the heart pump device market, underpinned by its advanced healthcare infrastructure, robust reimbursement frameworks, and the presence of major industry players. The region's leadership is also driven by strong investments in R&D and high rates of heart failure diagnosis and treatment. Europe follows closely, benefiting from structured transplant programs, government support, and rapid adoption of next-generation implantable devices. Meanwhile, Asia Pacific is projected to be the fastest-growing region during 2025-2035, owing to a rapidly aging population, increasing cardiovascular disease prevalence, and rising healthcare expenditure in countries like China, India, and Japan. Additionally, the growing footprint of medical device manufacturers, supportive regulatory reforms, and awareness programs in emerging economies are expected to further accelerate growth in this region.

Major market players included in this report are:

Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Jarvik Heart Inc.
Getinge AB
Abiomed Inc.
Berlin Heart GmbH
Terumo Corporation
Calon Cardio-Technology Ltd.
CorWave SA
ReliantHeart Inc.
SynCardia Systems LLC
LivaNova PLC
BiVACOR Inc.
CH Biomedical Inc.

Global Heart Pump Device Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product:

Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD)
Intra-aortic Balloon Pumps
Total Artificial Heart (TAH)

By Type:

Extracorporeal Pumps
Implantable Pumps

By Therapy:

Bridge-to-transplant
Destination Therapy

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Heart Pump Device Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Heart Pump Device Market Forces Analysis

3.1. Market Forces Shaping The Global Heart Pump Device Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising prevalence of end-stage heart failure and aging demographics
- 3.2.2. Advancements in implantable pumps (miniaturization, durability, remote monitoring) and expanding BTT/DT indications
3.3. Restraints
- 3.3.1. High acquisition and lifetime management costs with reimbursement complexities
- 3.3.2. Clinical risks (infection, thrombosis, device malfunction) and limited specialized implant centers
3.4. Opportunities
- 3.4.1. Accelerating adoption in APAC and emerging markets amid cardiovascular burden and infrastructure upgrades
- 3.4.2. Digital health integration and next-gen energy systems enabling home-based management and cost efficiencies

Chapter 4. Global Heart Pump Device Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Heart Pump Device Market Size & Forecasts by Product 2025-2035

5.1. Market Overview
5.2. Global Heart Pump Device Market Performance - Potential Analysis (2025)
5.3. Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD)
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Intra-aortic Balloon Pumps
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Total Artificial Heart (TAH)
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Heart Pump Device Market Size & Forecasts by Type & Therapy 2025-2035

6.1. Market Overview
6.2. Global Heart Pump Device Market Performance - Potential Analysis (2025)
6.3. Extracorporeal Pumps
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Implantable Pumps
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Bridge-to-transplant
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. Destination Therapy
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Heart Pump Device Market Size & Forecasts by Region 2025-2035

7.1. Heart Pump Device Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Heart Pump Device Market
- 7.3.1. U.S. Heart Pump Device Market
  - 7.3.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Heart Pump Device Market
  - 7.3.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Type & Therapy breakdown size & forecasts, 2025-2035
7.4. Europe Heart Pump Device Market
- 7.4.1. UK Heart Pump Device Market
  - 7.4.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Heart Pump Device Market
  - 7.4.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.4.3. France Heart Pump Device Market
  - 7.4.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Heart Pump Device Market
  - 7.4.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Heart Pump Device Market
  - 7.4.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Heart Pump Device Market
  - 7.4.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Type & Therapy breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Heart Pump Device Market
- 7.5.1. China Heart Pump Device Market
  - 7.5.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.5.2. India Heart Pump Device Market
  - 7.5.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Heart Pump Device Market
  - 7.5.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Heart Pump Device Market
  - 7.5.4.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Heart Pump Device Market
  - 7.5.5.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Heart Pump Device Market
  - 7.5.6.1. Product breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Type & Therapy breakdown size & forecasts, 2025-2035
7.6. Latin America Heart Pump Device Market
- 7.6.1. Brazil Heart Pump Device Market
  - 7.6.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Heart Pump Device Market
  - 7.6.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Type & Therapy breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Heart Pump Device Market
- 7.7.1. UAE Heart Pump Device Market
  - 7.7.1.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Heart Pump Device Market
  - 7.7.2.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Type & Therapy breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Heart Pump Device Market
  - 7.7.3.1. Product breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Type & Therapy breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Medtronic plc
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Abbott Laboratories
8.4. Abiomed Inc.
8.5. Berlin Heart GmbH
8.6. SynCardia Systems LLC
8.7. Jarvik Heart Inc.
8.8. Getinge AB
8.9. LivaNova PLC
8.10. Boston Scientific Corporation
8.11. Terumo Corporation